Updated:
DeepCardio
DeepCardio backs AI startups in cardiac diagnostics from Incheon, South Korea, focusing on digital health and machine learning for cardiovascular care.
DeepCardio
DeepCardio focuses on digital health startups that apply AI/ML to cardiac care. The firm is headquartered in Incheon, South Korea, and invests across Asian markets. It targets early-stage companies developing tools for ECG interpretation, imaging, and risk prediction (per public record). Strategy centers on AI-driven diagnostics. DeepCardio backs startups building software for arrhythmia detection, echocardiography analysis, and remote monitoring. The portfolio includes companies that integrate with hospital systems and wearable devices. It operates through direct startup investments in Asia (per public record). Deployment scale and team size are not publicly disclosed. No additional offices or adjacent vehicles are documented. Recent activity is not available in public sources. The structural differentiator is DeepCardio's narrow focus on AI in cardiology, a vertical within digital health that requires domain expertise. The firm's location in Incheon positions it near South Korea's healthcare technology ecosystem.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Incheon
Corporate office
Incheon, South Korea
Sector focus
Frequently asked questions
What does DeepCardio invest in?
DeepCardio invests in startups applying AI and machine learning to cardiac diagnostics. Focus areas include ECG analysis, medical imaging for the heart, and remote monitoring technologies. The firm targets early-stage companies in Asia.
Where is DeepCardio based?
DeepCardio is headquartered in Incheon, South Korea. Its operations are focused on Asian markets.
Does DeepCardio invest globally or only in Asia?
Public information indicates DeepCardio focuses on Asia. The firm's confirmed geography is Asia-based.
How does DeepCardio deploy capital?
DeepCardio deploys capital through direct investments in startups. It does not appear to operate fund-of-funds or major secondary structures based on available information.
Who runs DeepCardio?
Named principals are not publicly disclosed for DeepCardio. The firm's leadership is not identifiable from public records.
What is the investment stage for DeepCardio?
DeepCardio targets startups, implying early-stage investments. No specific stage band—seed, Series A, etc.—is confirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: